US Broker Ratings

ServiceTitan, Inc. (TTAN) Stock Analysis: Uncovering a 20.61% Potential Upside in the Tech Sector

ServiceTitan, Inc. (NASDAQ: TTAN) is gaining attention from investors, particularly within the technology sector, for its innovative approach to software applications. With a market capitalization of $9.38 billion, ServiceTitan stands..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Challenges and Opportunities in China’s Booming EdTech Sector

NetClass Technology Inc (NTCL), a player in the burgeoning Chinese edtech landscape, offers a multifaceted approach to online education and smart IT solutions. Despite a market capitalization of $40.83 million,..

Asana, Inc. (ASAN) Investor Outlook: Unpacking the 15.79% Potential Upside and Analyst Ratings

In a rapidly evolving digital landscape, Asana, Inc. (NYSE: ASAN) presents an intriguing opportunity for investors focused on the technology sector. As a key player in the software application industry,..

Dayforce, Inc. (DAY) Stock Analysis: Navigating a 10.96% Potential Upside in the Technological Realm

Dayforce, Inc. (NASDAQ: DAY), a prominent player in the technology sector, operates within the Software – Application industry, boasting a substantial market capitalization of $9.7 billion. As an innovator in..

Lyft, Inc. (LYFT) Stock Analysis: Navigating a 10% Potential Upside Amidst Tech Sector Volatility

Lyft, Inc. (NASDAQ: LYFT), a prominent name in the technology sector, operates a peer-to-peer marketplace for on-demand ridesharing across the United States and Canada. Beyond ridesharing, Lyft’s platform extends to..

Fastly, Inc. (FSLY) Stock Analysis: Navigating Volatility Amidst Tech Innovation

Fastly, Inc. (NYSE: FSLY), a prominent player in the edge cloud platform space, is commanding attention in the technology sector with its innovative offerings. With a market capitalization of $1.16..

Sprout Social, Inc (SPT) Stock Analysis: Exploring a 26.1% Potential Upside in the Social Media Management Sector

Sprout Social, Inc. (NASDAQ: SPT) is a prominent player in the technology sector, specifically within the software application industry. Known for its innovative web-based social media management platform, Sprout Social..

CS Disco, Inc. (LAW) Stock Analysis: Exploring a Potential 38% Upside in the Legal Tech Sector

Investors with an eye on the technology sector’s evolving landscape may find CS Disco, Inc. (NYSE: LAW) a compelling case study. Specializing in cloud-native and AI-driven legal solutions, CS Disco..

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook on a Volatile Healthcare Stock with a 52-Week High Potential

Zhengye Biotechnology Holding Limited (ZYBT), a player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents a captivating opportunity for investors seeking exposure to the..

DocuSign, Inc. (DOCU) Stock Analysis: Exploring a 15% Potential Upside Amid Tech Innovation

DocuSign, Inc. (NASDAQ: DOCU), a prominent player in the technology sector, continues to shape the future of digital agreements with its innovative electronic signature solutions. Headquartered in San Francisco, this..

Asure Software Inc (ASUR) Stock Analysis: A Promising 46.49% Upside in the Cloud-Based HCM Market

Asure Software Inc (NASDAQ: ASUR) operates in the dynamic Technology sector, specifically within the Software – Application industry. The Austin, Texas-based company specializes in providing cloud-based Human Capital Management (HCM)..

NANO-X IMAGING LTD (NNOX): Investor Outlook on a High-Potential Medical Device Innovator with 61.74% Upside

As the medical imaging landscape continues to evolve, NANO-X IMAGING LTD (NNOX) emerges as a notable player, capturing investor attention with its promise of innovation and significant potential upside. Headquartered..

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Navigating the Biotechnology Landscape with a 4.46% Potential Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is making waves in the biotechnology sector as it navigates the complex landscape of cancer therapeutics. With a market capitalization of $370.71 million, this commercial-stage..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a 157% Potential Upside and Robust Dividend Yield

XOMA Royalty Corporation (NASDAQ: XOMA) is capturing the attention of investors with its unique position in the biotechnology sector and an attractive potential upside of 157.74%. With a core focus..

Mereo BioPharma (MREO) Stock Analysis: Exploring the 187.96% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO) is drawing significant attention in investor circles, primarily due to its substantial potential upside of 187.96%. This UK-based biopharmaceutical company, with a market capitalization..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unpacking a 55% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to genetic medicines. With a market capitalization of $434.71 million,..

Shopify Inc. (SHOP) Stock Analysis: Revenue Growth Soars with Robust 26.80% Increase

As Shopify Inc. (SHOP) continues to solidify its presence as a leading player in the technology sector, the company’s impressive revenue growth and strategic positioning offer individual investors a unique..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: An Investor’s Insight into a Biotech with a 220% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) has caught the attention of the investment community with its promising potential upside of 220.40%, according to analyst ratings. This clinical-stage biopharmaceutical company specializes in..

Varex Imaging Corporation (VREX) Stock Analysis: A Potential 90% Upside in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity with a notable potential upside of 90.37%...

Fulcrum Therapeutics, Inc. (FULC): Investor Outlook with 10.86% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is increasingly capturing the attention of biotech investors with its promising pipeline and a notable potential upside of 10.86% as per recent analyst ratings. Positioned..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds